Clinical Trial Update: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 long-term study assessing height and weight outcomes in children with Mucopolysaccharidosis type II (Hunter syndrome) who began idursulfase treatment be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Elaprase (idursulfase)

Snippet

Sponsor: Shire | Conditions: Hunter Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2026-04-02